AZIENDA ULSS 4 VENETO ORIENTALE
Desconocido
REVERT: taRgeted thErapy for adVanced colorEctal canceR paTients
AZIENDA ULSS 4 VENETO ORIENTALE
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The REVERT project will address the specific challenge of understanding at system level the pathophysiology of mCRC cancer in patients respo...
2019-11-22 - 2024-12-31 | Financiado
2019-11-22 - 2024-12-31 | Financiado
EUCBCC: EUropean Cross Border Care CollaborationsShort Title CrossEurope
AZIENDA ULSS 4 VENETO ORIENTALE
participó en un
FP7:
EUCBCC aims to facilitate a process whereby Europe's citizens can make informed choices about whether to seek health care in another Member...
Financiado
Financiado
* No se disponen de datos de la empresa actual.